Slide 1: Q2 2019 Financial Results and Business Highlights
Q2 2019 Financial Results and Business Highlights August 14, 2019
Slide 2: Forward-looking statements
Forward-looking statements • “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements about the company and its products, including statements relating to components of the company’s long-term financial success; the com
Slide 3: HB4 drought tolerant soybeans now approved for commercialization in US, Brazil and Argentina
HB4® drought tolerant soybeans now approved for commercialization in US, Brazil and Argentina • USDA approval received in August, following FDA approval in 2017. Accelerating evaluation of US partners to introgress trait into their soy varieties. • Commercial approval in Brazil will follow public co
Slide 4: GoodWheat advances toward sales before year-end
GoodWheatTM advances toward sales before year-end • Building supply for first sales in 2019 • Introducing reduced gluten wheat retail flour in the US • Securing sales of resistant starch wheat in key global markets • Winter production was successful with greater than expected yields, spring producti
Slide 5: Announcing Archipelago Ventures - strategic hemp partnership with Legacy Ventures Hawaii
Announcing ArchipelagoTM Ventures - strategic hemp partnership with Legacy Ventures Hawaii • Joins Arcadia’s extensive genetic expertise and resources with Legacy’s proven experience in extraction and distribution • Creates one vertically integrated supply chain, from seed to sale, to deliver superi
Slide 6: First hemp harvest completed in Hawaii
First hemp harvest completed in Hawaii • Establishes Arcadia as leader in developing industrial hemp industry in Hawaii • Demonstrates capability to grow and harvest multiple hemp varieties for flower and CBD production • Cultivating varieties that can deliver commercial-level performance without ex
Slide 7: Arcadia Specialty Genomics is rapidly advancing R&D and breeding capabilities
Arcadia Specialty GenomicsTM is rapidly advancing R&D and breeding capabilities • Indoor growth facilities fully operational with breeding protocols easily replicated in all research settings • Internal platform to analyze cannabinoid and terpene profiles • CO2 extraction research capabilities in me